<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6708">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02120703</url>
  </required_header>
  <id_info>
    <org_study_id>173-SUR-ERC-10</org_study_id>
    <nct_id>NCT02120703</nct_id>
  </id_info>
  <brief_title>Pregabalin Compared to Gabapentin for Pain Control in Lumbar Disc Surgery</brief_title>
  <official_title>Gabapentin vs. Pregabalin for Post Operative Pain in Lumbar Microdiscectomy: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <authority>Pakistan: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregabalin is claimed to have superior analgesic effect at lower doses and better
      pharmacological profile as compared to gabapentin esp. in perioperative pain control after
      major surgeries like intervertebral disc surgery.

      The investigators found that pregabalin is equivalent to gabapentin for relief of
      post-operative pain at a lower dose in patients undergoing intervertebral disc surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain measurement using Visual Analogue Score at 24 hours and 7th day of surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Intervertebral Disc Prolapse</condition>
  <arm_group>
    <arm_group_label>gabapentin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregablin 75 mg per oral two times a day</description>
    <arm_group_label>Pregabalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Gabapentin 200 mg twice daily per oral</description>
    <arm_group_label>gabapentin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  30-60 years age

          -  Any gender

          -  elective micro discectomy for intervertebral disc prolapse

        Exclusion Criteria:

          1. micro discectomy at two or more vertebral levels,

          2. Instrumentation i.e. pedicle screw fixation, hooks etc.,

          3. history of steroids or alcohol use,

          4. Multiple co-morbids i.e. renal failure, chronic liver disease,

          5. use of anticonvulsant drugs,

          6. Spinal deformity,

          7. Obesity (BMI &gt;30), 8) inability to understand and respond VAS and

        9) patients with known allergy to GABA analogues.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohsin Qadeer, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Aga Khan University Hospital, Karachi, Pakistan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Aga Khan University Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sind</state>
        <zip>75300</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 22, 2014</lastchanged_date>
  <firstreceived_date>April 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aga Khan University</investigator_affiliation>
    <investigator_full_name>Ghulam Murtaza</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Pregabalin</keyword>
  <keyword>gabapentin</keyword>
  <keyword>microdiscectomy</keyword>
  <keyword>pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Intervertebral Disk Displacement</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
